| 1. |
- Chi Fru, Ernest, et al.
(författare)
-
Sedimentary mechanisms of a modern banded iron formation on MIlos Island, Greece
- 2018
-
Ingår i: Solid Earth. - : European Geosciences Union (EGU). - 1869-9510 .- 1869-9529. ; 9, s. 573-598
-
Tidskriftsartikel (refereegranskat)abstract
- An early Quaternary shallow submarine hydrothermal iron formation (IF) in the Cape Vani sedimentary basin (CVSB) on Milos Island, Greece, displays banded rhythmicity similar to Precambrian banded iron formation (BIF). Field-wide stratigraphic and biogeochemical reconstructions show two temporal and spatially isolated iron deposits in the CVSB with distinct sedimentological character. Petrographic screening suggests the presence of a photoferrotrophic-like microfossil-rich IF (MFIF), accumulated on a basement consisting of andesites in a ∼ 150m wide basin in the SW margin of the basin. A banded nonfossiliferous IF (NFIF) sits on top of the Mn-rich sandstones at the transition to the renowned Mn-rich formation, capping the NFIF unit. Geochemical data relate the origin of the NFIF to periodic submarine volcanism and water column oxidation of released Fe(II) in conditions predominated by anoxia, similar to the MFIF. Raman spectroscopy pairs hematite-rich grains in the NFIF with relics of a carbonaceous material carrying an average δ13Corg signature of ∼ −25‰. A similar δ13Corg signature in the MFIF could not be directly coupled to hematite by mineralogy. The NFIF, which postdates large-scale Mn deposition in the CVSB, is composed primarily of amorphous Si (opal-SiO2 ⋅ nH2O) while crystalline quartz (SiO2) predominates the MFIF. An intricate interaction between tectonic processes, changing redox, biological activity, and abiotic Si precipitation are proposed to have collectively formed the unmetamorphosed BIF-type deposits in a shallow submarine volcanic center. Despite the differences in Precambrian ocean–atmosphere chemistry and the present geologic time, these formation mechanisms coincide with those believed to have formed Algoma-type BIFs proximal to active seafloor volcanic centers.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Metra, Marco, et al.
(författare)
-
y Effects of Serelaxin in Patients with Acute Heart Failure
- 2019
-
Ingår i: New England Journal of Medicine. - : MASSACHUSETTS MEDICAL SOC. - 0028-4793 .- 1533-4406. ; 381:8, s. 716-726
-
Tidskriftsartikel (refereegranskat)abstract
- BackgroundSerelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies have suggested that treatment with serelaxin may result in relief of symptoms and in better outcomes in patients with acute heart failure. MethodsIn this multicenter, double-blind, placebo-controlled, event-driven trial, we enrolled patients who were hospitalized for acute heart failure and had dyspnea, vascular congestion on chest radiography, increased plasma concentrations of natriuretic peptides, mild-to-moderate renal insufficiency, and a systolic blood pressure of at least 125 mm Hg, and we randomly assigned them within 16 hours after presentation to receive either a 48-hour intravenous infusion of serelaxin (30 mu g per kilogram of body weight per day) or placebo, in addition to standard care. The two primary end points were death from cardiovascular causes at 180 days and worsening heart failure at 5 days.ResultsA total of 6545 patients were included in the intention-to-treat analysis. At day 180, death from cardiovascular causes had occurred in 285 of the 3274 patients (8.7%) in the serelaxin group and in 290 of the 3271 patients (8.9%) in the placebo group (hazard ratio, 0.98; 95% confidence interval [CI], 0.83 to 1.15; P=0.77). At day 5, worsening heart failure had occurred in 227 patients (6.9%) in the serelaxin group and in 252 (7.7%) in the placebo group (hazard ratio, 0.89; 95% CI, 0.75 to 1.07; P=0.19). There were no significant differences between the groups in the incidence of death from any cause at 180 days, the incidence of death from cardiovascular causes or rehospitalization for heart failure or renal failure at 180 days, or the length of the index hospital stay. The incidence of adverse events was similar in the two groups.ConclusionsIn this trial involving patients who were hospitalized for acute heart failure, an infusion of serelaxin did not result in a lower incidence of death from cardiovascular causes at 180 days or worsening heart failure at 5 days than placebo. (Funded by Novartis Pharma; RELAX-AHF-2 ClinicalTrials.gov number, NCT01870778.) In a randomized trial, 6545 patients with acute heart failure were assigned to either serelaxin or placebo in addition to standard care. There were no significant differences between the two groups in the incidence of death from cardiovascular causes at 180 days or worsening heart failure at 5 days.
|
|
| 6. |
- Szilas, Kristoffer, et al.
(författare)
-
Highly refractory Archaean peridotite cumulates : Petrology and geochemistry of the Seqi Ultramafic Complex, SW Greenland
- 2018
-
Ingår i: Geoscience Frontiers. - : Elsevier BV. - 1674-9871. ; 9:3, s. 689-714
-
Tidskriftsartikel (refereegranskat)abstract
- This paper investigates the petrogenesis of the Seqi Ultramafic Complex, which covers a total area of approximately 0.5 km2. The ultramafic rocks are hosted by tonalitic orthogneiss of the ca. 3000 Ma Akia terrane with crosscutting granitoid sheets providing an absolute minimum age of 2978 ± 8 Ma for the Seqi Ultramafic Complex. The Seqi rocks represent a broad range of olivine-dominated plutonic rocks with varying modal amounts of chromite, orthopyroxene and amphibole, i.e. various types of dunite (s.s.), peridotite (s.l.), as well as chromitite. The Seqi Ultramafic Complex is characterised primarily by refractory dunite, with highly forsteritic olivine with core compositions having Mg# ranging from about 91 to 93. The overall high modal contents, as well as the specific compositions, of chromite rule out that these rocks represent a fragment of Earth's mantle. The occurrence of stratiform chromitite bands in peridotite, thin chromite layers in dunite and poikilitic orthopyroxene in peridotite instead supports the interpretation that the Seqi Ultramafic Complex represents the remnant of a fragmented layered complex or a magma conduit, which was subsequently broken up and entrained during the formation of the regional continental crust. Integrating all of the characteristics of the Seqi Ultramafic Complex points to formation of these highly refractory peridotites from an extremely magnesian (Mg# ∼ 80), near-anhydrous magma, as olivine-dominated cumulates with high modal contents of chromite. It is noted that the Seqi cumulates were derived from a mantle source by extreme degrees of partial melting (>40%). This mantle source could potentially represent the precursor for the sub-continental lithospheric mantle (SCLM) in this region, which has previously been shown to be ultra-depleted. The Seqi Ultramafic Complex, as well as similar peridotite bodies in the Fiskefjord region, may thus constitute the earliest cumulates that formed during the large-scale melting event(s), which resulted in the ultra-depleted cratonic keel under the North Atlantic Craton. Hence, a better understanding of such Archaean ultramafic complexes may provide constraints on the geodynamic setting of Earth's first continents and the corresponding SCLM.
|
|
